Program

FDA Medical Device User Fee Program

Department: HHS

The cabinet-level department or independent agency responsible for the program

Agency: Food and Drug Administration

The specific agency or sub-agency that administers the program

Program Type:Regulatory / Enforcement

The functional category of the program

In Official FIP? Not represented

(Additional HHS detail row added beneath broader carrier.)

Confidence Level: Detail / zero-carry

Authorizing Statute: 21 U.S.C. 379j

Funding Status: See carrier row

Primary Source: https://obamaadministration.archives.performance.gov/federalprograminventory.html

Notes: FDA Medical Device User Fee Program nested beneath Medical Device Premarket Review Program.

Additional details about data sources and custom mapping of data are available on the Data Details page.

Outlays (millions)

Actual money spent in FY2024

$0

Source: TAS-based mapping (high confidence)

Obligations (millions)

Money the government committed to spend in FY2024

$0

Source: TAS-based mapping (high confidence)

Budget Authority (millions)

The amount Congress authorized agencies to commit

$0

Source: 0 entered intentionally; this is a detail row nested under ‘Medical Device Premarket Review Program’ to increase program visibility without double counting. See Fiscal Method.

Revenue Loss (millions)

Estimated revenue not collected due to tax policy (tax expenditures)

$0

Source: TAS-based mapping (high confidence)

Primary Amount

The primary fiscal measure used for the program

$0

Dollar Basis

The primary fiscal measure used for the program

Outlays

Note: Detail row added in reconciliation round; dollars remain on broader carrier row ‘Medical Device Premarket Review Program’.

Dollar Quality

How directly the dollar amount reflects observed data

Carry-Zero

Actual = reported or observed spending, Estimated = derived from modeling or mapping, Carry-Zero = structural row with no direct dollars